{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:27:17Z","timestamp":1789770437195,"version":"4.0.1"},"reference-count":15,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":889,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Neurol Scand"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1111\/ane.12107","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T08:34:38Z","timestamp":1364286878000},"page":"166-171","source":"Crossref","is-referenced-by-count":42,"title":["Inhaled dry powder apomorphine (VR040) for \u2018off\u00a0\u2019 periods in Parkinson's disease: an in-clinic double-blind dose ranging study"],"prefix":"10.1155","volume":"128","author":[{"given":"K. A.","family":"Grosset","sequence":"first","affiliation":[{"name":"Department of Neurology; Institute of Neurological Sciences; Southern General Hospital; Glasgow; UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Malek","sequence":"additional","affiliation":[{"name":"Department of Neurology; Institute of Neurological Sciences; Southern General Hospital; Glasgow; UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Morgan","sequence":"additional","affiliation":[{"name":"Vectura Group plc; Chippenham; Wiltshire; UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. G.","family":"Grosset","sequence":"additional","affiliation":[{"name":"Department of Neurology; Institute of Neurological Sciences; Southern General Hospital; Glasgow; UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2013,3,26]]},"reference":[{"key":"10.1111\/ane.12107-BIB0001|ane12107-cit-0001","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/jnnp.53.2.96","article-title":"Subcutaneous apomorphine in the treatment of Parkinson's disease","volume":"53","author":"Frankel","year":"1990","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/ane.12107-BIB0002|ane12107-cit-0002","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/mds.870130505","article-title":"A double-blind, placebo-controlled study of intranasal apomorphine spray as a rescue agent for off-states in Parkinson's disease","volume":"13","author":"Dewey","year":"1998","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12107-BIB0003|ane12107-cit-0003","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00003088-199937030-00004","article-title":"Pharmacokinetic-pharmacodynamic relationships of apomorphine in patients with Parkinson's disease","volume":"37","author":"Neef","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/ane.12107-BIB0004|ane12107-cit-0004","unstructured":"Grosset K Morgan F Grosset D Phase IIa randomized double-blind, placebo-controlled, study of inhaled apomorphine in patients with established Parkinson's disease Kyoto, Japan"},{"key":"10.1111\/ane.12107-BIB0005|ane12107-cit-0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-8993(87)90619-6","article-title":"Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study","volume":"400","author":"Carlson","year":"1987","journal-title":"Brain Res"},{"key":"10.1111\/ane.12107-BIB0006|ane12107-cit-0006","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/mds.870090613","article-title":"The dopamine D1 agonist SKF 81297 and the dopamine D2 agonist LY 171555 act synergistically to stimulate motor behaviour of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian rhesus monkeys","volume":"9","author":"Vermeulen","year":"1994","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12107-BIB0007|ane12107-cit-0007","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s100720170062","article-title":"Subcutaneous continuous apomorphine infusion in fluctuating patients with Parkinson's disease: long-term results","volume":"22","author":"Stocchi","year":"2001","journal-title":"Neurol Sci"},{"key":"10.1111\/ane.12107-BIB0008|ane12107-cit-0008","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ana.410260209","article-title":"Peripheral pharmacokinetics of apomorphine in humans","volume":"26","author":"Gancher","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1111\/ane.12107-BIB0009|ane12107-cit-0009","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jnnp.56.1.101","article-title":"Apomorphine in treatment of Parkinson's disease: comparison between subcutaneous and sublingual routes","volume":"56","author":"Deffond","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/ane.12107-BIB0010|ane12107-cit-0010","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1002\/mds.23158","article-title":"Comparison of orally dissolving carbidopa\/levodopa (Parcopa) to conventional oral carbidopa\/levodopa: a single-dose, double-blind, double-dummy, placebo-controlled, crossover trial","volume":"25","author":"Ondo","year":"2010","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12107-BIB0011|ane12107-cit-0011","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00002826-200311000-00012","article-title":"Pharmacokinetics of etilevodopa compared to levodopa in patients with Parkinson's disease: an open-label, randomized, crossover study","volume":"26","author":"Djaldetti","year":"2003","journal-title":"Clin Neuropharmacol"},{"key":"10.1111\/ane.12107-BIB0012|ane12107-cit-0012","unstructured":"A double-blind, placebo-controlled, parallel-group, proof of concept trial to assess the tolerability, safety, and efficacy of rotigotine nasal spray for the acute treatment of \u201cOFF\u201d symptoms in subjects with advanced-stage, Idiopathic Parkinson Disease"},{"key":"10.1111\/ane.12107-BIB0013|ane12107-cit-0013","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/mds.23206","article-title":"Melevodopa\/carbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinson's disease","volume":"25","author":"Stocchi","year":"2010","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12107-BIB0014|ane12107-cit-0014","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/mds.22922","article-title":"Orodispersible sublingual piribedil to abort off episodes: a single dose placebo-controlled, randomized, double-blind, cross-over study","volume":"25","author":"Rascol","year":"2010","journal-title":"Mov Disord"},{"key":"10.1111\/ane.12107-BIB0015|ane12107-cit-0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF03192285","article-title":"Apomorphine pharmacokinetics in parkinsonism after intranasal and subcutaneous application","volume":"20","author":"Sam","year":"1995","journal-title":"Eur J Drug Metab Pharmacokinet"}],"container-title":["Acta Neurologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fane.12107","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ane.12107\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T12:46:42Z","timestamp":1671540402000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ane.12107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,26]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"URL":"https:\/\/doi.org\/10.1111\/ane.12107","relation":{},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3,26]]}}}